Why urinary biomarkers should be used for the surveillance of non-muscle-invasive bladder cancer. A discussion by an international expert panel at the 19th Meeting of the EAU Section of Oncological Urology (ESOU22), held on 21-23 January 2022 in Madrid, Spain.

SOCIAL MEDIA

Subscribe to one of our social media channels

close

Subscription Confirmation Required

Go to your email inbox

Go to your email inbox

Go to the inbox of the email
address you just used to sign up.

Open the confirmation email

Open the confirmation email

Find the email sent by us. It has the subject line
“Nucleix: Please Confirm Subscription” and I
sent from “info@nucleix.com”.

Click the confirmation link

Click the confirmation link

Click on the link inside the
email and you’re good to go.

GOT IT !